Branded CoronaVac in some regions, it is the second Chinese developed vaccine to win such WHO listing to combat Covid-19. - AFP
GENEVA (Reuters): The World Health Organization (WHO) said on Tuesday (June 1) it has approved a Covid-19 vaccine made by Sinovac Biotech for emergency use listing, paving the way for a second Chinese shot to be used in poor countries.
A WHO emergency listing is a signal to national regulators of a product's safety and efficacy and will allow the Sinovac shot to be included in Covax, the global programme providing vaccines mainly for poor countries, which faces major supply problems due to curbs on Indian exports.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
